DOI: 10.17151/vetzo.2017.11.1.8
How to Cite
Osorio-Carmona, E. ., Cássia-Santana, G. de ., Castro Varón, J. A. ., Alves Ramalho, G. ., Guimarães Reis, L. ., Jaramillo-Colorado, S. ., & de Faria Rezende, C. M. . (2017). Efeito precoce do concentrado autólogo de plaquetas sobre a osteoartrose induzida em coelhos: Níveis plasmáticos de PDGF e TGF-β1 e seu potencial como biomarcadores . Revista Veterinaria Y Zootecnia (On Line), 11(1), 96–115. https://doi.org/10.17151/vetzo.2017.11.1.8

Authors

Esteban Osorio-Carmona
Universidade Federal de Minas Gerais
freosorio105@gmail.com
Gilcinéa de Cássia-Santana
Universidade Federal de Minas Gerais
a@a.com
Jessica Alejandra Castro Varón
Universidade Federal de Minas Gerais
a@a.com
Gustavo Alves Ramalho
Universidade Federal de Minas Gerais
a@a.com
Luciana Guimarães Reis
Universidade Federal de Minas Gerais
a@a.com
Santiago Jaramillo-Colorado
Universidade Federal de Minas Gerai
a@a.com
Cleuza Maria de Faria Rezende
Universidade Federal de Minas Gerais
a@a.com

Abstract

O objetivo da presente pesquisa foi determinar a concentração dos fatores de crescimento PDGF e TGF-β1 no plasma de coelhos com osteoartrose induzida pela ruptura do ligamento cruzado cranial e tratados com concentrado autólogo de plaquetas ou Ringer Lactato intra-articular. Foram empregados 14 coelhos machos, adultos, com massa corporal média de 3,0 kg, da raça Nova Zelândia que foram divididos em dois grupos (I e II). Amostras de sangue foram coletadas antes da ruptura do ligamento cruzado cranial (momento 1), no momento da substituição do mesmo (momento 2) e duas semanas após a reparação do ligamento (momento 3) e submetidas a centrifugação para se obter o plasma. A concentração dos fatores de crescimento foi avaliada empregando-se kits de ELISA específicos para a espécie e para os fatores de crescimento. Nos coelhos do grupo concentrado autólogo de plaquetas verificou-se diferença estatisticamente significativa (P<0,05) nos níveis do PDGF no momento 3 quando comparados com o grupo que recebeu a solução de Ringer Lactato intraarticular. Os níveis plasmáticos do TGF-β1 apresentaram diferença estatisticamente significativa (P<0,05) no grupo controle quando comparados o momento 1 com o momento 2 e o momento 3, porém não foi observada diferença significativa quando comparados com o grupo que recebeu o concentrado autólogo de plaquetas em nenhum dos momentos avaliados. Conclui-se, portanto, que o PDGF pode ser usado como parâmetro de avaliação precoce do efeito do concentrado autólogo de plaquetas intraarticular.

 Anitua, S.; Prado, R.; Sánchez, M. et al. Platelet-rich plasma: preparation and formulation.Operative Technique in Orthopaedic, v.22, p. 25-32. 2012.

 Argüelles, D.; Carmona, J.U.; Pastor, J. et al. Evaluation of single and double centrifugation tube methods for concentrating equine platelets. Research in Veterinary Science, v.81, p.237-245. 2006.

 Baksh, N.; Hannon, C.P.; Murawski, C.D. et al. Platelet-rich plasma in tendon models: a systematic review of basic science literature. Arthroscopy, v. 29, n. 3, p. 596-607. 2013.

 Bauer, D.C.; Hunter, D.J.; Abramson, S.B. et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis and Cartilage, v.14, p.723-727. 2006.

 Behnke, O.; Forer, A. From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream. European Journal of Haematology, v.60, p.3-24, 1998.

 Bennett, N.T.; Schultz, G.S. Growth factors and wound healing: Biochemical properties of growth factors and their receptors. American Journal of Surgery, v.165, n.6, p.728- 737. 1993.

 Bonnet, C.S.; Walsh, D.A. Osteoarthritis, angiogenesis, and inflammation. Rheumatology (Oxford), v.44, n. 1, p.7-16. 2005.

 Boswell, S.G.; Cole, B.J.; Sundman, E.A. Platelet-rich plasma: a milieu of bioactive factors.Arthroscopy, v.28, n.3, p.429-439. 2012.

 Broughton II, G.; Janis, J.E.; Attinger, C.E. The basic science of wound healing. Plastic and Reconstructive Surgery, v.117, p.12S-32S, 2006a (Suppl.7).

 Broughton II, G.; Janis, J.E.; Attinger, C.E. Wound Healing: An Overview. Plastic and Reconstructive Surgery, v.117, p.1e-S-32e-S, 2006b (Suppl.7).

 Carmona, J.U.; López, C. Autologous platelet concentrates as a treatment for shoulder injury in a horse. case report. Journal of Equine Veterinary Science, v.31, n.9, p. 506- 510. 2011.

 Carmona, J.U.; López, C.; Giraldo, C.E. Uso de concentrados autólogos de plaquetas como terapia regenerativa de enfermedades crónicas del aparato musculoesquelético equino.Archivo de
Medicina Veterinaria, v.43, n.1, p.1-10. 2011.

 Carrasco, J.; Bonete, D.; Gomar, R. Plasma rico en plaquetas vs. plasma rico em factores de crecimiento. Revista Española de Cirugía Osteoarticular, v.46, n.239, p.127-140. 2009.

 Cheon, H.; Yu, S.J.; Yoo, D.H. et al. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-b1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clinical and Experimental Immunology, v.127, n.3, p.547-552. 2002.

 Civinini, R.; Macera, A.; Nistri, L. et al. The use of autologous blood-derived growth factors in bone regeneration. Clinical Cases Mineral Bone Metabolism, v.8, n.1, p.25- 31, 2011.

 Colburn, W.A.; De Gruttola, V.G.; De Mets, D.L. et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Biomarkers Definitions Working Group. Clinical Pharmacological & Therapeutics, v.69, p. 89-95. 2001

 Ehrenfest, D.M.D.; Rasmusson, L.; Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (LPRF). Trends in Biotechnology, v. 27, n. 3, p. 158-167. 2008.

 Flores, J.R.; Gallego, M.A.P.; García-Denche, J.T. Plasma rico en plaquetas: fundamentos biológicos y aplicaciones en cirugía maxilofacial y estética facial. Revista Española de Cirugía Oral y Maxilofacial, v. 34, n. 1, p. 8-17. 2012.

 Harrison, P. Platelet function analysis. Blood Reviews, v.19, n.2, p.111-123. 2005.

 Hakimi, M.; Jungbluth, P.; Sager, M. et al. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. InjuryInternational Journal
of the Care of the Injured, v.41, n.7, p. 717-723. 2010.

 Iacopetti, I.; Perazzi, A.; Ferrari, V. et al. Application of platelet-rich gel to enhance wound healing in the horse: A case report. Journal of Equine Veterinary Science, v.32, n.3, p.123-128. 2012.

 Intini, G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials, v.30, n.28, p.4956-4966. 2009.

 Kang, H.J.; Kang, E.S. Ideal concentration of growth factors in rabbit’s flexor tendon culture.Yonsei Medical Journal, v.40, n.1, p.26-29. 1999.

 Kim, J.H; Park, C.; Park, H.M. Curative effect of autologous platelet-rich plasma on a large cutaneous lesion in a dog. Veterinary Dermatology, v.20, n.2, p. 123-126. 2008.

 Kon, E.; Filardo, G.; Di Matteo, B. et al. Platelet-rich plasma in sports medicine: new treatment for tendon and cartilage lesions. Operative Techniques in Orthopaedics, v.22, n.2, p.78-85. 2012.

 Kraus, V.B.; Blanco, F.J.; Englund, M. OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis. Osteoarthritis and Cartilage, v.23, p.686-697, 2015.

 Kraus, V.B.; Burnett, B.; Coindreau, J. et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis and Cartilage, v.19, p.515-542, 2011.

 Lagunas, J.G. Plasma rico en plaquetas. Revista Española de Cirugía Oral y Maxilofacial, v.28, n.2, p.89-99. 2006.

 Lawrence, W.; Diegelmann, R. Growth factors in wound healing. Clinics in Dermatology, v.12, n.1, p.157-169. 1994.

 Lee, A.J.; Chung, W.H.; Kim, D.H. et al. Anterior cruciate ligament reconstruction in a rabbit model using canine small intestinal submucosa and autologous platelet-rich plasma. Journal of Surgery Research, v.178, n.1, p.206-215. 2012.

 Lynch, S.E.; Williams, R.C.; Polson, A.M. et al. A combination of platelet derived and insulin-like growth factors enhances periodontal regeneration. Journal of Periodontology, v. 16, n. 8, p. 545-548. 1989.

 Marx, R.E. Platelet-rich plasma: evidence to support its use. Journal of Oral and Maxillofacial Surgery, v. 62, n. 4, p. 489-496. 2004.

 Matsuda, N.; Lin, W.L.; Kumar, N.M. et al. Mitogenic, chemostatic, synthetyc responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. Journal of Periodontology, v.63, n.6, p.515-25. 1992.

 Milano, G.; Sanna-Passino, E.; Deriu, L. et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep
model. Osteoarthritis and Cartilage, v.18, n.7, p.971-980. 2010.

 Mishra, A.; Woodall, J.; Vieira, M. Treatment of tendon and muscle using platelet-rich plasma. Clinics in Sports Medicine, v.28, n.1, p.113–125. 2009.

 Niu, T.; Rosen, C.J. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene, v.361, p.38-56. 2005.

 Osorio-Carmona, E.; Rezende, C.M.F. Osteoartrose: aspectos clínicos e novas perspectivas terapêuticas baseadas na terapia regenerativa. Veterinaria y Zootecnia, v.8, n.2, p.49-71. 2014.

 Patel, S.; Dhillon, M.S.; Aggarwal, S. et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial.American Journal of Sports Medicine, v.41, n.2, p.356-364. 2013.

 Petrigliano, F.P.; McAllister, D.R.; Wu, B.M. Tissue engineering for anterior cruciate ligament reconstruction: A review of current strategies. Journal of Arthroscopic Related Surgery, v.22, n.4, p.441-451. 2006.

 Rezende, M.U de.; Campos, G.C de. A osteoartrite é uma doença mecânica ou inflamatória?Revista Brasileira de Ortopedia, v.48, n.6, p.471-474. 2013.

 Riedel, K.; Riedel, F.; Goessler, U.R. et al. TGF-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro. Archives of Medical Research, v.38, n.1, p.45-51. 2007.

 Saito, M.; Takahashi, K.A.; Arai, Y. et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clinical and Experimental Rheumatology, v. 27, n. 2, p. 201-207. 2009.

 Sánchez, M; Azofra, J; Anitua, E. et al. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Medicine and Science in Sports and Exercise, v.35, n.10, p.1648-1652. 2003.

 Schawalder, P.; Gitterle, E. Eigene methoden zur operativen rekonstruktion bei rupturen des vorderen und hinteren kreuzbandes. Kleintierpraxis, v.7, p.323-330, 1989.

 Schwartz, A.; Martinez-Sanchez, G.; Re, L. Growth factors derived from platelet and its applications in regenerative medicine. Potential use of ozone as activator. Revista Española de Ozonoterapia, v.1, n.1, p.54-73. 2011.

 Silva, R.F. Caracterizações celular e ultra-estrutural do concentrado de plaquetas em cães e gatos e avaliação do seu efeito na osteoartrose em cães. Belo Horizonte, Brasil: Universidade Federal de Minas Gerais, 2012. 88f. Tese (Doutorado em ciência animal).

 Silva, R.F.; Rezende, C.M.F; Paes-Leme, F.O. et al. Evaluación del método del tubo para concentrar plaquetas caninas: estudio celular. Archivos de Medicina Veterinaria, v.43, n.1, p.95-98. 2011a.

 Silva, R.F; Rezende, C.M.F; Paes-Leme, F.O. et al. Evaluación del método del tubo para concentrar plaquetas felinas: estudio celular. Archivos de Medicina Veterinaria, v.43, n.2, p.187-190. 2011b.

 Smith, S.E.; Roukis, T.S. Bone and wound healing augmentation with platelet-rich plasma.Clinics in Podiatric Medicine and Surgery, v.26, n.4, p.559-588. 2009.

 Sohn, D.H.; Sokolove, J.; Sharpe, O. et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Research and Therapy, v.14, n.1, p.R7. 2012.

 Textor, J. Autologous biologic treatment for equine musculoskeletal injuries: Plateletrich plasma and IL-1 receptor antagonist protein. Veterinary Clinics of North America. Equine Practice, v.27, n.2, p.275-298. 2011.

 Tiwari, M.; Bhargava, R. Platelet rich plasma therapy: a comparative effective therapy with promising results in plantar fasciitis. Journal of Clinics Orthopaedics and Trauma, v.4, n.1, p.31-35. 2013.

 Vagdatli, E.; Gonari, E.; Lazaridou, E. et al. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia, v.14, n.1, p.28- 32, 2010.

 Virchenko, O.; Aspenberg, P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthopaedica, v.77, n.5, p.806-812. 2006.

 Wasterlain, A.S.; Braun, H.J.; Dragoo, J.L. Contents and formulations of platelet-rich plasma. Operative Technique in Orthopaedics, v.22, n.1, p.33-42. 2012.

 Weibrich, G; Hansen, T; Kleis, W. et al. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone, v.34, n.4, p.665-671. 2004.

 Xie, X.; Wu, H. Zhao, S. et al. The effect of platelet-rich plasma on patterns of gene expression in a dog model of anterior cruciate ligament reconstruction. Journal of Surgery Research, v.180, n.1, p.80-88. 2013a.

 Xie, X.; Zhao, S.; Wu, H. et al. Platelet-rich plasma enhances autograft revascularization and reinnervation in a dog model of anterior cruciate ligament reconstruction. Jounal of Surgery Research, v.183, n.1, p.214-222. 2013b.

Downloads

Download data is not yet available.
Sistema OJS - Metabiblioteca |